Category: pharma & healthcare

New Big Data Study Investigates How People With Cancer Fare When They Get Covid-19

Researchers have found that some people with cancer are more at risk of severe or fatal Covid-19 outcomes than others.

What Restarting Sports And Reopening Schools Have In Common

Studying and learning from the successes and failures of so-called sports “bubbles” helps us think through the decisions we now face on whether to reopen schools—and if they do reopen, what we might expect.

Biden/Harris Likely To Favor Medicare For More And Public Option

While Medicare for More and the public option do not reform the current patchwork system wholesale, they may address several issues that voters appear to care about, including improving equitable access to health insurance and lowering patient out-of-p…

Why A Joe Biden And Kamala Harris Administration Could Be A Big Boost For Cancer Research

Both candidates have strong personal reasons to prioritize funding for cancer research if they are elected in November.

CMS Proposes Changes To Medicaid Best Price Rule: A Potential Boost To Value-Based Contracting

The proposed changes to the Medicaid best price rule put forward by CMS may give drug manufacturers and payers regulatory flexibility to encourage more use of value-based contracting arrangements for expensive, but promising therapies.

Two-Step Testing Could Slow Covid-19 Transmission Dramatically

The two-step method is not only a better way to test, but could potentially reduce transmission by 50 percent or more—and do so quickly.

Klobuchar Asks GAO To Examine Prescription Drug Rebate Traps

Rebate traps constitute ways to “entrench the dominance of [branded] products for as long as possible by limiting the ability of alternative drugs to compete,” thereby restricting patient access to lower cost generic drugs and biosimilars, as well as o…

Cancer Diagnoses Drop Almost 50% During Coronavirus Pandemic

People aren’t developing fewer cancers, they just aren’t being diagnosed, which could impact survival rates.

Seroprevalence Studies May Underestimate Immunity To The Coronavirus

Dr. Rajkumar is convinced that seroprevalence studies greatly underestimate the true level of immunity of a given population to the novel coronavirus. Antibody production upon exposure to the virus, existing antibodies, and T cells all contribute to im…

Coronavirus Bar Outbreaks Plague Global Re-Opening Attempts

Growing evidence is showing that bars are hot spots for coronavirus outbreaks around the world. Do we really need to fully re-open these businesses?